
Cicatrisant collagen compress are biomaterials performed from type I collagen purified. Experimental studies including trials carried out in vitro and in vivo, demonstrated the biocompatibility of these biomaterials and their effect on accelerating the process of dermic wound re-epithelization. A subsequent stage of our investigations consisted in clinical trial of these cicatrisant compresses. These were applied to post-traumatismal wounds of variable areas or to 2nd and 3rd degree of deeper burns. The obtained results demonstrated that collagen biomaterials as cicatrizing compresses are well tolerated by human organism, they do not cause inflammations, necroses or other undesirable phenomena at the site of application. Also it was found that these biomaterials are not antigenic, since anticollagen type I antibodies were not present in nome of the treated patients' serum and accelerate the epitelization.
Treatment Outcome, Humans, Wounds and Injuries, Collagen, Occlusive Dressings, Burns
Treatment Outcome, Humans, Wounds and Injuries, Collagen, Occlusive Dressings, Burns
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
